Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid
Isoniazid is a first-line antibiotic used in the treatment of infections caused by Mycobacterium tuberculosis. Isoniazid is a prodrug requiring oxidative activation by the catalase-peroxidase hemoprotein, KatG. Resistance to isoniazid can be obtained by point mutations in the katG gene, with one of...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
2002
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127408/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12183226/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.9.2765-2771.2002 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
